Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (9): 981-984.DOI: 10.3969/j.issn.1673-8640.2021.09.020
Previous Articles Next Articles
Received:2020-02-14
Online:2021-09-30
Published:2021-09-24
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.09.020
| 参数 | 中值 | 高值 | |||
|---|---|---|---|---|---|
| $\bar{x}±s$ | CV/% | $\bar{x}±s$ | CV/% | ||
| RET# | （0.048±0.003）% | 6.41 | （0.077±0.03）% | 4.07 | |
| RET% | （0.92±0.06）×1012/L | 6.00 | （1.77±0.08）×1012/L | 4.41 | |
| IRF% | （39.47±2.22）% | 5.62 | （48.51±3.35）% | 6.90 | |
| LFR% | （61.04±2.71）% | 4.45 | （51.49±3.35）% | 6.50 | |
| MFR% | （30.76±2.66）% | 8.64 | （38.84±2.61）% | 6.71 | |
| HFR% | （8.71±1.04）% | 11.93 | （9.67±1.39）% | 14.40 | |
| RET-HE | （25.43±0.34）pg | 1.34 | （24.12±0.18）pg | 0.74 | |
| Micro-R% | （1.78±0.13）% | 7.51 | （4.52±0.38）% | 8.51 | |
| Macro-R% | （4.66±0.10）% | 2.13 | （4.12±0.10）% | 2.53 | |
| Hypo-HE% | （0.360±0.050）% | 13.96 | （0.705±0.069）% | 9.73 | |
| Hyper-HE% | （0.425±0.044）% | 10.45 | （0.255±0.051）% | 20.02 | |
| 参数 | 中值 | 高值 | |||
|---|---|---|---|---|---|
| $\bar{x}±s$ | CV/% | $\bar{x}±s$ | CV/% | ||
| RET# | （0.048±0.003）% | 6.41 | （0.077±0.03）% | 4.07 | |
| RET% | （0.92±0.06）×1012/L | 6.00 | （1.77±0.08）×1012/L | 4.41 | |
| IRF% | （39.47±2.22）% | 5.62 | （48.51±3.35）% | 6.90 | |
| LFR% | （61.04±2.71）% | 4.45 | （51.49±3.35）% | 6.50 | |
| MFR% | （30.76±2.66）% | 8.64 | （38.84±2.61）% | 6.71 | |
| HFR% | （8.71±1.04）% | 11.93 | （9.67±1.39）% | 14.40 | |
| RET-HE | （25.43±0.34）pg | 1.34 | （24.12±0.18）pg | 0.74 | |
| Micro-R% | （1.78±0.13）% | 7.51 | （4.52±0.38）% | 8.51 | |
| Macro-R% | （4.66±0.10）% | 2.13 | （4.12±0.10）% | 2.53 | |
| Hypo-HE% | （0.360±0.050）% | 13.96 | （0.705±0.069）% | 9.73 | |
| Hyper-HE% | （0.425±0.044）% | 10.45 | （0.255±0.051）% | 20.02 | |
| 参数 | 单位 | 基线值x（95%可信区间） | 标准误 | 与基线值的差异 | 稳定时间/h | |||
|---|---|---|---|---|---|---|---|---|
| 12 h | 24 h | 48 h | 72 h | |||||
| RET% | % | 2.055（1.611~2.500） | 0.217 4 | -0.074 | -0.123 | -0.043 | 0.059 | 72 |
| RET# | ×1012/L | 0.082 0（0.065 8~0.098 3） | 0.007 9 | -0.002 8 | -0.005 5 | -0.001 9 | 0.002 3 | 72 |
| IRF% | % | 13.84（11.18~16.51） | 1.30 | -0.24 | -0.89 | -0.94 | -1.81① | 48 |
| LFR% | % | 86.18（83.62~88.73） | 1.25 | -0.28 | 0.08 | 0.73 | 1.38① | 48 |
| MFR% | % | 10.55（9.07~12.02） | 0.72 | 0.20 | -0.33 | -0.78① | -1.24① | 24 |
| HFR% | % | 3.55（2.12~4.98） | 0.67 | -0.27 | -0.37 | -0.27 | -0.88① | 48 |
| RET-HE | pg | 31.73（30.54~32.92） | 0.58 | -0.55 | -0.61① | -0.99① | -1.23① | 12 |
| Micro-R% | % | 2.50（0.77~4.22） | 0.84 | -0.36 | -0.77 | -1.21① | -1.47① | 24 |
| Macro-R% | % | 5.49（3.99~6.97） | 0.73 | 1.81① | 4.20① | 8.00① | 9.80① | <12 |
| Hypo-HE% | % | 1.56（0.65~2.48） | 0.44 | -0.19 | -0.26 | -0.43 | -0.47① | 48 |
| Hyper-HE% | % | 0.41（0.30~0.51） | 0.05 | 0.01 | -0.01 | -0.05 | -0.07① | 48 |
| 参数 | 单位 | 基线值x（95%可信区间） | 标准误 | 与基线值的差异 | 稳定时间/h | |||
|---|---|---|---|---|---|---|---|---|
| 12 h | 24 h | 48 h | 72 h | |||||
| RET% | % | 2.055（1.611~2.500） | 0.217 4 | -0.074 | -0.123 | -0.043 | 0.059 | 72 |
| RET# | ×1012/L | 0.082 0（0.065 8~0.098 3） | 0.007 9 | -0.002 8 | -0.005 5 | -0.001 9 | 0.002 3 | 72 |
| IRF% | % | 13.84（11.18~16.51） | 1.30 | -0.24 | -0.89 | -0.94 | -1.81① | 48 |
| LFR% | % | 86.18（83.62~88.73） | 1.25 | -0.28 | 0.08 | 0.73 | 1.38① | 48 |
| MFR% | % | 10.55（9.07~12.02） | 0.72 | 0.20 | -0.33 | -0.78① | -1.24① | 24 |
| HFR% | % | 3.55（2.12~4.98） | 0.67 | -0.27 | -0.37 | -0.27 | -0.88① | 48 |
| RET-HE | pg | 31.73（30.54~32.92） | 0.58 | -0.55 | -0.61① | -0.99① | -1.23① | 12 |
| Micro-R% | % | 2.50（0.77~4.22） | 0.84 | -0.36 | -0.77 | -1.21① | -1.47① | 24 |
| Macro-R% | % | 5.49（3.99~6.97） | 0.73 | 1.81① | 4.20① | 8.00① | 9.80① | <12 |
| Hypo-HE% | % | 1.56（0.65~2.48） | 0.44 | -0.19 | -0.26 | -0.43 | -0.47① | 48 |
| Hyper-HE% | % | 0.41（0.30~0.51） | 0.05 | 0.01 | -0.01 | -0.05 | -0.07① | 48 |
| 参数 | 单位 | 基线值x（95%可信区间） | 标准误 | 与基线值的差异 | 稳定时间/h | |||
|---|---|---|---|---|---|---|---|---|
| 12 h | 24 h | 48 h | 72 h | |||||
| RET# | ×1012/L | 0.081 7（0.064 9~0.098 4） | 0.008 2 | -0.000 7 | -0.000 6 | -0.000 9 | -0.002 9 | 72 |
| IRF% | % | 13.82（11.27~16.38） | 1.25 | 0.34 | -0.53 | -0.73 | -1.38① | 48 |
| LFR% | % | 86.16（83.49~88.82） | 1.30 | -0.05 | 0.89 | 0.44 | 1.18 | 72 |
| MFR% | % | 10.40（9.00~11.80） | 0.69 | 0.18 | -0.63 | -0.28 | -0.48 | 72 |
| HFR% | % | 3.30（1.99~4.60） | 0.64 | 0.15 | 0.28 | 0.02 | -0.20 | 72 |
| RET-HE | pg | 31.36（30.12~32.59） | 0.60 | 0.26 | 0.39 | 0.55 | 0.44 | 72 |
| Micro-R% | % | 2.74（0.93~4.55） | 0.88 | 0.01 | 0.14 | 0.07 | -0.02 | 72 |
| Macro-R% | % | 4.86（3.78~5.94） | 0.53 | 0.02 | -0.13 | -0.06 | 0.01 | 72 |
| Hypo-HE% | % | 1.09（0.40~1.77） | 0.33 | -0.05 | -0.08 | -0.13 | -0.15 | 72 |
| Hyper-HE% | % | 0.41（0.31~0.51） | 0.05 | 0.01 | 0.01 | -0.01 | -0.02 | 72 |
| 参数 | 单位 | 基线值x（95%可信区间） | 标准误 | 与基线值的差异 | 稳定时间/h | |||
|---|---|---|---|---|---|---|---|---|
| 12 h | 24 h | 48 h | 72 h | |||||
| RET# | ×1012/L | 0.081 7（0.064 9~0.098 4） | 0.008 2 | -0.000 7 | -0.000 6 | -0.000 9 | -0.002 9 | 72 |
| IRF% | % | 13.82（11.27~16.38） | 1.25 | 0.34 | -0.53 | -0.73 | -1.38① | 48 |
| LFR% | % | 86.16（83.49~88.82） | 1.30 | -0.05 | 0.89 | 0.44 | 1.18 | 72 |
| MFR% | % | 10.40（9.00~11.80） | 0.69 | 0.18 | -0.63 | -0.28 | -0.48 | 72 |
| HFR% | % | 3.30（1.99~4.60） | 0.64 | 0.15 | 0.28 | 0.02 | -0.20 | 72 |
| RET-HE | pg | 31.36（30.12~32.59） | 0.60 | 0.26 | 0.39 | 0.55 | 0.44 | 72 |
| Micro-R% | % | 2.74（0.93~4.55） | 0.88 | 0.01 | 0.14 | 0.07 | -0.02 | 72 |
| Macro-R% | % | 4.86（3.78~5.94） | 0.53 | 0.02 | -0.13 | -0.06 | 0.01 | 72 |
| Hypo-HE% | % | 1.09（0.40~1.77） | 0.33 | -0.05 | -0.08 | -0.13 | -0.15 | 72 |
| Hyper-HE% | % | 0.41（0.31~0.51） | 0.05 | 0.01 | 0.01 | -0.01 | -0.02 | 72 |
| [1] | 葛国兴, 张铭媛. 网织血红蛋白含量在小细胞阴性贫血中的早期诊断价值[J]. 中国卫生检验杂志, 2019, 29(11):1351-1353. |
| [2] |
URRECHAGA E, BORQUE L, ESCANERO J F. Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability[J]. Int J Lab Hematol, 2013, 35(2):144-149.
DOI URL |
| [3] |
BRUGNARA C, SCHILLER B, MORAN J. Reticulocyte hemoglobin equivalent(Ret He) and assessment of iron-deficient states[J]. Clin Lab Haematol, 2006, 28(5):303-308.
DOI URL |
| [4] | JOOSTEN E, HIELE M, GHOOS Y, et al. Diagnosis of iron-deficiency anemia in a hospitalized geriatric population[J]. Am J Med, 1991, 90(5):653-654. |
| [5] | 杨尚瑜, 雷娇, 李雪. 健康成人静脉血常规标本室温放置不同时间对结果的影响分析[J]. 吉林医学, 2018, 39(6):1050-1052. |
| [6] | 金芳, 龙建成, 张春霞. Sysmex XN20 A1全自动血细胞分析仪性能评价[J]. 中国医学装备, 2016, 13(8):31-34. |
| [7] | 李绵绵, 李芳, 余玲玲, 等. 新型网织红细胞参数在贫血早期诊断中的价值[J]. 中国卫生检验杂志, 2019, 29(11):1289-1291. |
| [8] |
URRECHAGA E, BORQUE L, ESCANERO J F. The role of automated measurement of RBC subpopulations in differential diagnosis of microcytic anemia and β-thalassemia screening[J]. Am J Clin Pathol, 2011, 135(3):374-379.
DOI URL |
| [9] |
ROONEY S, HOFFMANN J J, CORMACK O M, et al. Screening and confirmation of hereditary spherocytosis in children using a CELL-DYN Sapphire haematology analyser[J]. Int J Lab Hematol, 2015, 37(1):98-104.
DOI URL |
| [10] |
URRECHAGA E, BORQUE L, ESCANERO J F. The role of automated measurement of red cell subpopulations on the Sysmex XE 5000 analyzer in the differential diagnosis of microcytic anemia[J]. Int J Lab Hematol, 2011, 33(1):30-36.
DOI URL |
| [11] | HOFFMANN J J, VAN DEN BROEK N M, CURVERS J. Reference intervals of extended erythrocyte and reticulocyte parameters[J]. Clin Chem Lab Med, 2012, 50(5):941-948. |
| [12] | 陈梅, 方伟祯, 傅玉如. Sysmex XE-2100全自动血细胞分析仪分析网织红细胞性能评价[J]. 实用医学杂志, 2007, 23(2):268-270. |
| [13] | 曾叶, 吕维敏, 黄钢妹, 等. 血液红细胞的低温保存[J]. 低温与超导, 2014, 42(9):25-29. |
| [14] |
FREISE K J, SCHMIDT R L, GINGERICH E L, et al. The effect of anticoagulant,storage temperature and dilution on cord blood hematology parameters over time[J]. Int J Lab Hematol, 2009, 31(5):496-504.
DOI URL |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
